BioCentury
ARTICLE | Financial News

InterMune down on lowered guidance

June 12, 2003 7:00 AM UTC

ITMN was off $8.36 (33%) to $16.74 on 18.1 million shares on Thursday. Post-market Wednesday, ITMN lowered 2003 sales guidance for its Actimmune interferon gamma-1b to $135-$150 million from $160-$180...